TrialClinical journal of the American Society of Nephrology : CJASN2024

Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.